Abridge · Series E Extension
Enterprise-grade AI for clinical conversations, trusted by the largest healthcare systems to improve outcomes at scale.
Amount
$316M
Round
Series E Extension
Valuation
$5.3B
Announced
Apr 2026
Investors
Lead investor
Participating investors
Notes
funding refresh